General Population Survey 2018/19.
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is one of five EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15).
Deadline
The time limit for receipt of tenders was 2018-06-25.
The procurement was published on 2018-05-18.
Suppliers
The following suppliers are mentioned in award decisions or other procurement documents:
Object Scope of the procurement
Title:
“Survey to determine the prevalence of the use of illicit drugs, alcohol, prescription drugs and gambling in the general population
HRB 2018 - Gen Pop Survey”
Products/services: Survey conduction services📦
Short description:
“General Population Survey 2018/19.
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and...”
Short description
General Population Survey 2018/19.
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is 1 of 5 EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15).
Show more
Total value of the procurement (excluding VAT): EUR 574 675 💰
1️⃣
Additional products/services: Survey services📦
Additional products/services: Survey design services📦
Place of performance: Éire/Ireland🏙️
Description of the procurement:
“The Health Research Board (HRB) is the lead agency in Ireland supporting and funding health research. We provide funding, maintain health information...”
Description of the procurement
The Health Research Board (HRB) is the lead agency in Ireland supporting and funding health research. We provide funding, maintain health information systems and conduct research linked to national health priorities. Our aim is to improve people's health, build health research capacity and make a significant contribution to Ireland's knowledge economy. Our latest Corporate Strategy clearly outlines how we hope to achieve this working in partnership with other organizations.
General Population Survey 2018/19.
Prevalence and patterns of drug use among the general population, measured by probabilistic surveys of the adult and school population, is 1 of 5 EMCDDA key indicators that assess the drugs situation and allow monitoring of progress towards EU and Member State drug policy targets. The aim of this key indicator is to provide valid, reliable and comparable information on the extent, the distribution and the patterns of drug use in the general population (adults and young people), the characteristics of drug users and their perceptions. Each Member State is required to complete a regular survey to estimate national drug use prevalence and Ireland has conducted four of these general population surveys (2002/03, 2006/07, 20010/11 and 2014/15). 1 Previous surveys were conducted simultaneously in Ireland and Northern Ireland (on behalf of the Public Health Information and Research Branch (PHIRB), within the Department of Health, Social Services and Public Safety). The 2018/19 survey will be conducted in Ireland only.
1) Survey brief:
The Health Research Board will commission a fifth survey, to be completed between September 2018 and April 2019. The survey will require a nationally representative proability sample of the persons aged 15 years and over and resident in households in Ireland. The sample size will be in the order of 8 302. The survey will use a pre-prepared questionnaire and interviews will be conducted face-to-face in respondents’ homes using CAPI.
Show more Award criteria
Quality criterion (name): Experience in managing large population surveys
Quality criterion (weighting): 35 %
Quality criterion (name): Qualifications of staff assigned to this project
Quality criterion (weighting): 10 %
Quality criterion (name): Ability to deliver key outputs to a tight deadline
Quality criterion (name):
“Understanding of the requirements of the contract and feasibility of the proposed plan”
Quality criterion (name):
“Clarity in outlining the proposed plan, including details around milestones and data analysis”
Quality criterion (weighting): 10
Price (weighting): 25 %
Procedure Type of procedure
Open procedure
Administrative information
Previous publication concerning this procedure: 2018/S 096-219063
Award of contract
1️⃣
Contract Number: 1
Title:
“Survey to determine the prevalence of the use of illicit drugs, alcohol, prescription drugs and gambling in the general population”
Date of conclusion of the contract: 2018-09-28 📅
Information about tenders
Number of tenders received: 4
Number of tenders received by electronic means: 4
Name and address of the contractor
Name: Ipsos MRBI / MRBI Market Research Ltd
National registration number: 9701145N
Postal address: Block 3 Blackrock Business Park
Postal town: Co Dublin
Postal code: Carysfort Avenue, Bl
Country: Ireland 🇮🇪
Phone: +353 14389048📞
E-mail: kieran.oleary@ipsos.com📧
Region: Éire/Ireland🏙️
URL: http://www.ipsosmrbi.com🌏
The contractor is an SME
Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot: EUR 574 675 💰
Complementary information Review body
Name: High Court
Postal address: Chief Registrar, The Four Courts
Postal town: Dublin
Postal code: 7
Country: Ireland 🇮🇪
Phone: +353 18886000📞
E-mail: highcourtcentraloffice@courts.ie📧
Source: OJS 2018/S 228-522055 (2018-11-22)